Ethylenediamine

Ethylenediamine

SCHEMBL583838

NCCN.O=P(O)(O)CCCC(P(=O)(O)O)(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE3A known ✓ Q14432 2/20 0.43
PDE4D known ✓ Q08499 1/20 0.41
LMNA P02545 2/20 0.56
CYP3A4 P08684 1/20 0.56
NFKB1 P19838 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
ALDH1A1 P00352 3/20 0.48
TYMS P04818 1/20 0.46
FDPS P14324 6/20 0.43
ADRB3 P13945 1/20 0.41
GRM4 Q14833 1/20 0.40
TDP1 Q9NUW8 1/20 0.38
LPAR2 Q9HBW0 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10764074 0.91 TYMS (0.55) LMNACYP3A4NFKB1BLMPMP22
SCHEMBL20699854 0.82 LPAR3 (0.50) LMNACYP3A4NFKB1BLMPMP22
SCHEMBL1260815 0.82 LPAR3 (0.50) LMNACYP3A4NFKB1BLMPMP22
SCHEMBL11630697 0.80 LPAR3 (0.48) LMNACYP3A4NFKB1BLMPMP22
SCHEMBL19211969 0.78 GRM4 (0.52) LMNACYP3A4NFKB1BLMPMP22
Ethylenediamine SCHEMBL69119 0.78 LMNA (0.78) LMNACYP3A4NFKB1BLMPMP22
Ethylenediamine SCHEMBL10933099 0.78 LMNA (0.78) LMNACYP3A4NFKB1BLMPMP22
Ethylenediamine SCHEMBL4154009 0.76 LMNA (0.74) LMNACYP3A4NFKB1BLMPMP22
Ethylenediamine SCHEMBL5157252 0.76 LMNA (0.74) LMNACYP3A4NFKB1BLMPMP22
Ethylenediamine SCHEMBL15053407 0.76 LMNA (0.74) LMNACYP3A4NFKB1BLMPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0203523-B1 ALKALINE HYDROXIDE-CONTAINING COMPOUNDS IN MELTED BLOCK FORM FOR MACHINE DISH-WASHING, AND PROCESS FOR THEIR PREPARATION Henkel Kommanditgesellschaft auf Aktien (DE) 1991-01-23 EP claimed
US-4569838-A GELLING AGENT OF IOTA-CARRAGEENAN AND XANTHAN GUM MIXTURE WITH PHOSPHONATE ANTINUCLEATING AGENT COLGATE-PALMOLIVE COMPANY (US) 1986-02-11 US claimed
CN-112726126-B Scale inhibition washing drum for clothes treatment device and preparation method thereof 云米互联科技(广东)有限公司 2023-06-13 CN disclosed
CN-112726133-B Scale inhibition outer cylinder for clothes treatment device and preparation method thereof 云米互联科技(广东)有限公司 2023-06-13 CN disclosed
US-11208619-B2 Unit dose detergent products with effect on protein stains Henkel IP & Holding GmbH (DE) 2021-12-28 US disclosed
US-11154625-B2 Fucoidans as ligands for the diagnosis of degenerative pathologies INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2021-10-26 US disclosed
US-20210054317-A1 Unit Dose Detergent Products With Effect On Protein Stains Henkel IP & Holding GmbH (DE) 2021-02-25 US disclosed
EP-3156078-B1 FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES INST NAT SANTE RECH MED (FR) 2020-03-04 EP disclosed
EP-3156078-A1 FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES UNIVERSITE PARIS-NORD 13 (FR) 2017-04-19 EP disclosed
EP-2416806-B1 FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES UNIVERSITÉ PARIS 13 (FR) 2016-12-14 EP disclosed
US-20150337308-A1 MATRIX METALLOPROTEINASE 9 (MMP-9) APTAMER AND USES THEREOF CHU DE BORDEAUX (FR) 2015-11-26 US disclosed
WO-2013153138-A1 MATRIX METALLOPROTEINASE 9 (MMP-9) APTAMER AND USES THEREOF INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2013-10-17 WO disclosed
US-20120183475-A1 Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2012-07-19 US disclosed
US-20120093725-A1 Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) 2012-04-19 US disclosed
EP-2416806-A1 FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2012-02-15 EP disclosed
WO-2010116209-A1 FUCOIDANS AS LIGANDS FOR THE DIAGNOSIS OF DEGENERATIVE PATHOLOGIES INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2010-10-14 WO disclosed
US-4929380-A Process for the preparation of a storage-stable liquid detergent composition HENKEL KOMMANDITGESELLSCHAFT AUG AKTIEN (DE) 1990-05-29 US disclosed
US-4820436-A Detergents for low laundering temperatures HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1989-04-11 US disclosed
US-4774014-A Detergent supply pack and process for production HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1988-09-27 US disclosed
US-4569838-A GELLING AGENT OF IOTA-CARRAGEENAN AND XANTHAN GUM MIXTURE WITH PHOSPHONATE ANTINUCLEATING AGENT COLGATE-PALMOLIVE COMPANY (US) 1986-02-11 US disclosed